Sep 03, 2026
August Jobs Report Preview: What Would Make a Fed Hike a Done Deal?

Friday’s August employment report could break a high-stakes deadheat for the Federal Reserve. CME FedWatch futures price a 50-50 split between a pause at 3.50%–3.75% and a 25-basis-point hike at the Sept. 16 FOMC meeting. Rate-hike odds surged past 63%…

Sep 03, 2026
Snowflake Just Lit Up the AI Trade: This ETF Explodes 45%

The T-Rex 2X Long SNOW Daily Target ETF (BATS:SNOU) surged up on Thursday as Snowflake Inc. (NYSE:SNOW) shares jumped over 22% following a strong fiscal second-quarter report and upbeat guidance. • Snowflake shares are testing new highs. What’s behind SNOW new…

Sep 03, 2026
SunPower Stock Surges Thursday: What’s Happening?

Shares of SunPower Corp. (NASDAQ:SPWR) are surging Thursday afternoon after the solar energy technology company secured a crucial cash injection. SunPower stock is showing exceptional strength. What’s behind SPWR gains? $26.2 Million Capital Raise Led by Silicon Valley Venture Capitalists…

Sep 03, 2026
Tesla Stock’s Next Move Hinges on Cybercab: Morgan Stanley

Tesla Inc. (NASDAQ:TSLA) shares jumped Thursday as traders positioned ahead of the company’s highly anticipated Cybercab event this evening in Austin, Texas. The rally comes as Morgan Stanley analysts laid out a binary setup for the stock in a note previewing…

Sep 03, 2026
Why Is Cipher Digital Stock Surging Thursday?

Cipher Digital Inc. (NASDAQ:CIFR) stock traded higher Thursday as crypto-linked assets gained momentum.Comments from Federal Reserve Gov. Christopher Waller may have added to the risk-on sentiment. Waller said he is inclined to support keeping interest rates steady, according to Benzinga…

Sep 03, 2026
Walmart Stock Gains on Broad Market Rally and New Delivery Partnership

Shares of Walmart Inc. (NASDAQ:WMT) are trading higher Thursday afternoon as the retail giant benefits from broader market tailwinds and fresh expansion within its delivery ecosystem. Here’s what investors need to know. Walmart stock is showing upward movement. Why is…

Sep 03, 2026
Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial

Aptevo Therapeutics Inc. (NASDAQ:APVO) announced that its lead candidate mipletamig achieved a 93% clinical benefit rate when administered as a triplet therapy to frontline acute myeloid leukemia patients carrying TP53 mutations. The clinical-stage biotechnology firm develops multispecific immuno-oncology therapeutics to…